Dr. Hlalah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 SW Archer Rd
Gainesville, FL 32610Phone+1 352-273-7832Fax+1 352-273-7849
Education & Training
East Tennessee State University/Quillen College of MedicineFellowship, Medical Oncology, 2003 - 2005
Mercy Catholic Medical CenterResidency, Internal Medicine, 2000 - 2003
University of Jordan Faculty of MedicineClass of 1995
Certifications & Licensure
FL State Medical License 2008 - 2026
LA State Medical License 2024 - 2025
KY State Medical License 2005 - 2008
VA State Medical License 2003 - 2006
PA State Medical License 2001 - 2003- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
Clinical Trials
- A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer Start of enrollment: 2016 May 11
- TR(ACE) Assay Clinical Specimen Study Start of enrollment: 2016 Sep 01
Publications & Presentations
PubMed
- 16 citationsEflapegrastim, a Long-Acting Granulocyte-Colony Stimulating Factor for the Management of Chemotherapy-Induced Neutropenia: Results of a Phase III Trial.Lee S. Schwartzberg, Gajanan Bhat, Julio Antonio Peguero, Richy Agajanian, Jayaram S. Bharadwaj
The Oncologist. 2020-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
